CBR-096-4

CAT: 0804-HY-117485Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-117485Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
CBR-096-4 is a derivative of Itraconazole (HY-17514) . CBR-096-4 is an orally active antifibrotic agent with no CYP3A4 inhibitory activity. CBR-096-4 inhibits the formation of matrix-secreting activated myofibroblasts (MFBs) from multiple tissue types. CBR-096-4 inhibits Hedgehog reporter activity (GLI-LUC), VEGF-dependent growth, and αSMA-LUC reporter activity. CBR-096-4 can be used for research of fibrosis[1].
CAS Number
[1776931-05-5]
UNSPSC
12352005
Target
Hedgehog
Related Pathways
Stem Cell/Wnt
Field of Research
Inflammation/Immunology
Smiles
O=C1N(C(C)CC)N=CN1C2=CC=C(N3CCN(C4=CC=C(OC[C@@H]5O[C@](C6=CC=CC=C6)(CN7N=CC=N7)OC5)C=C4)CC3)C=C2
Molecular Formula
C35H40N8O4
Molecular Weight
636.74
References & Citations
[1]Bollong MJ, et al. Small molecule-mediated inhibition of myofibroblast transdifferentiation for the treatment of fibrosis. Proc Natl Acad Sci U S A. 2017 May 2;114 (18) :4679-4684.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-120516-01CDE-096
HY-145986CBR-6672
HY-100012-01CBR-5884
HY-145985CBR-3465
HY-151107CBR Agonist-2
HY-134205A-01CBR-470-1
HY-151105CBR Agonist-1
HY-134001-01CBR-470-2
HY-157447CBR1-IN-4
HY-W099255-01Ethyl 4,4,4,4',4',4'-hexafluoro-DL-valinate

Alternative Products

CatalogName
BA8056-5CDE-096
ABC-TC0667MEL-CBR-4
7240/1ZNL 02-096
533532ZNL-02-096
MBS5814004Sdz 210-096
99-691-CISISLET GRADIENT 1.096
M22643-01CBR-5884
ABC-TC0608LS-CBR
MBS5803748CBR-3465
ABC-TC0409HS1-CBR

Popular Products